DE69316621D1 - Antivitale zusammensetzungen - Google Patents

Antivitale zusammensetzungen

Info

Publication number
DE69316621D1
DE69316621D1 DE69316621T DE69316621T DE69316621D1 DE 69316621 D1 DE69316621 D1 DE 69316621D1 DE 69316621 T DE69316621 T DE 69316621T DE 69316621 T DE69316621 T DE 69316621T DE 69316621 D1 DE69316621 D1 DE 69316621D1
Authority
DE
Germany
Prior art keywords
pct
sec
combinations
pharmaceutically acceptable
antivital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69316621T
Other languages
English (en)
Other versions
DE69316621T2 (de
Inventor
Janet Mary Cameron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69316621D1 publication Critical patent/DE69316621D1/de
Publication of DE69316621T2 publication Critical patent/DE69316621T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69316621T 1992-07-16 1993-07-13 Antivitale zusammensetzungen Expired - Lifetime DE69316621T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215178A GB9215178D0 (en) 1992-07-16 1992-07-16 Antiviral combinations
PCT/EP1993/001847 WO1994002155A1 (en) 1992-07-16 1993-07-13 Antiviral combinations

Publications (2)

Publication Number Publication Date
DE69316621D1 true DE69316621D1 (de) 1998-02-26
DE69316621T2 DE69316621T2 (de) 1998-05-07

Family

ID=10718844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69316621T Expired - Lifetime DE69316621T2 (de) 1992-07-16 1993-07-13 Antivitale zusammensetzungen

Country Status (12)

Country Link
US (1) US5612333A (de)
EP (1) EP0650363B1 (de)
JP (1) JPH07508998A (de)
AT (1) ATE162401T1 (de)
AU (1) AU672022B2 (de)
CA (1) CA2140238C (de)
DE (1) DE69316621T2 (de)
DK (1) DK0650363T3 (de)
ES (1) ES2111755T3 (de)
GB (1) GB9215178D0 (de)
GR (1) GR3026141T3 (de)
WO (1) WO1994002155A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660917B1 (fr) * 1990-04-11 1992-11-20 Perrier Rene Pince de prehension et machine de traitement d'objets, notamment de bouteilles, ainsi equipee.
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU1775592A (en) * 1991-04-03 1992-11-02 Richardson-Vicks Inc. Stabilized emulsion compositions for imparting an artificial tan to human skin
CZ285232B6 (cs) * 1991-05-16 1999-06-16 Glaxo Group Limited Protivirové směsi

Also Published As

Publication number Publication date
CA2140238A1 (en) 1994-02-03
DE69316621T2 (de) 1998-05-07
ES2111755T3 (es) 1998-03-16
DK0650363T3 (da) 1998-09-21
EP0650363A1 (de) 1995-05-03
EP0650363B1 (de) 1998-01-21
AU4568993A (en) 1994-02-14
CA2140238C (en) 2004-04-20
GR3026141T3 (en) 1998-05-29
ATE162401T1 (de) 1998-02-15
WO1994002155A1 (en) 1994-02-03
GB9215178D0 (en) 1992-08-26
US5612333A (en) 1997-03-18
JPH07508998A (ja) 1995-10-05
AU672022B2 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
MY109796A (en) 1,3-oxathiolane nucleoside analogues.
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
MA26458A1 (fr) Nouveaux derives cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent.
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
FR2757522B1 (fr) Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
GEP20022647B (en) Synergistic Combinations
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
RU94013464A (ru) Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции
FR2762843B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
MXPA03005464A (es) Agentes antivirales.
BR0114610A (pt) Composto, uso do mesmo, e, composição farmacêutica
ES2172533T3 (es) Uso de nonapeptidos y decapeptidos para la preparacion de un medicamento para combatir el sida.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
AR012868A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN PÉPTIDO AGONISTA DE LHRH, UN ANTAGONISTA DE LHRH O UN PÉPTIDO DE GRF Y NICOTINAMIDA.
DE69316621D1 (de) Antivitale zusammensetzungen
SE0001916D0 (sv) Novel formulation
BR9808823A (pt) (-)e-2- (3,4-diclorocinamil) -1-ciclopropilmetil-piperidina e seu uso antidiarréico
YU34793A (sh) Derivati proteina c

Legal Events

Date Code Title Description
8364 No opposition during term of opposition